Login / Signup

From Benign Lipoma to G3 Liposarcoma: Contrast-Enhanced Ultrasound Reveals Tumor Microperfusion and Indicates Malignancy.

Paul MickMarie RohnerTobias RenkawitzBurkhard LehnerAndreas GeisbüschStefanos TsitlakidisMustafa HaririJulian DeisenhoferMichelle MüllerJulian Doll
Published in: Ultrasound in medicine & biology (2024)
Our study suggests CEUS as a capable non-invasive tool for improving preoperative assessment of lipomatous STT. It can assist in the distinction between benign and malignant STT, accelerating treatment decisions and enhancing patient outcomes. Significant correlations between CEUS-derived parameters and malignancy highlight its risk assessment potential.
Keyphrases
  • contrast enhanced ultrasound
  • risk assessment
  • human health
  • patients undergoing
  • heavy metals
  • smoking cessation
  • clinical evaluation